REFERENCES
SECTION 03 REFERENCES
Alexander & Ziv (2023) Neuroendocrine Tumors: Genomics and Molecular Biomarkers wit
AMEND: https://www.amend.org.uk/
British Nuclear Medicine Society - PatientsCarers page. https://www.bnms.org.uk/page/P
Clement et al (2019). Nutritional and vitamin status in patients with neuroendocrine neopla
Clement, Ramage & Sririjaskanthan (2020) Update on Pathophysiology, Treatment, and C org/10.1155/2020/8341426 Coulter A, Collins A. Making shared decision making a reality. “No decision about me, with ing-shared-decision-making-reality
Cuthbertson, Shankland & Sririjaskanthan (2023) Diagnosis and management of neuroen
Das, Stockton, & Hassan (2023) Carcinoid Heart Disease Management: A Multi-Disciplina
Delhomme et al. (2023) Carcinoid heart disease in patients with midgut neuroendocrine tu
GMC Good medical practice. https://www.gmc-uk.org/ethical-guidance/ethical-guidance-fo
GMC Code of conduct for Council members. https://www.gmc-uk.org/about/how-we-work/
Laing et al (2020) Nutritional Complications and the Management of Patients with Gastroe
Laing et al (2022) Prevalence of malnutrition and nutrition-related complications in patients https://doi.org/10.1111/jne.13116
myhealth@QEHB Information available at https://archive.uhb.nhs.uk/myhealth-at-QEHB.h
NHS England Consent Available from https://www.nhs.uk/conditions/consent-to-treatment
Made with FlippingBook - Share PDF online